Weiss, SA; Sznol, M; Shaheen, M; Berciano-Guerrero, MA; Couselo, EM; Rodríguez-Abreu, D; Boni, V; Schuchter, LM; Gonzalez-Cao, M; Arance, A; Wei, W; Ganti, AK; Hauke, RJ; Berrocal, A; Iannotti, NO; Hsu, FJ; Kluger, HM – 2024 – 10.1158/1078-0432.CCR-23-0475
A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy – CLINICAL CANCER RESEARCH
by prodriguez | Jan 1, 2024 | Publicaciones - BE-23 | 0 comments